Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by François-Xavier Lescure and France Mentré.
François-Xavier Lescure
Connection Strength
0.553
France Mentré
  1. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 06; 20(6):697-706.
    View in: PubMed
    Score: 0.218
  2. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
    View in: PubMed
    Score: 0.059
  3. Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort. Proc Natl Acad Sci U S A. 2021 02 23; 118(8).
    View in: PubMed
    Score: 0.058
  4. Corrigendum to "Review of trials currently testing treatment and prevention of COVID-19" [Clin Microbiol Infect 26.8 (2020) 988-998]. Clin Microbiol Infect. 2021 Mar; 27(3):499.
    View in: PubMed
    Score: 0.058
  5. Review of trials currently testing treatment and prevention of COVID-19. Clin Microbiol Infect. 2020 Aug; 26(8):988-998.
    View in: PubMed
    Score: 0.055
  6. Type 1 interferons as a potential treatment against COVID-19. Antiviral Res. 2020 06; 178:104791.
    View in: PubMed
    Score: 0.055
  7. Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial. BMJ Open. 2018 09 01; 8(8):e023151.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.